"Brain Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
Descriptor ID |
D001932
|
MeSH Number(s) |
C04.588.614.250.195 C10.228.140.211 C10.551.240.250
|
Concept/Terms |
Brain Neoplasms- Brain Neoplasms
- Neoplasms, Brain
- Brain Neoplasm
- Neoplasm, Brain
- Brain Tumors
- Brain Tumor
- Tumor, Brain
- Tumors, Brain
Brain Cancer- Brain Cancer
- Brain Cancers
- Cancer, Brain
- Cancers, Brain
- Malignant Neoplasms, Brain
- Brain Malignant Neoplasm
- Brain Malignant Neoplasms
- Malignant Neoplasm, Brain
- Cancer of Brain
- Cancer of the Brain
- Neoplasms, Brain, Malignant
- Brain Neoplasms, Malignant
- Brain Neoplasm, Malignant
- Malignant Brain Neoplasm
- Malignant Brain Neoplasms
Brain Tumor, Recurrent- Brain Tumor, Recurrent
- Brain Tumors, Recurrent
- Recurrent Brain Tumor
- Recurrent Brain Tumors
Malignant Primary Brain Tumors- Malignant Primary Brain Tumors
- Primary Malignant Brain Tumors
- Malignant Primary Brain Neoplasms
- Primary Malignant Brain Neoplasms
- Brain Neoplasms, Malignant, Primary
- Brain Neoplasms, Primary Malignant
Benign Neoplasms, Brain- Benign Neoplasms, Brain
- Benign Neoplasm, Brain
- Brain Benign Neoplasm
- Brain Benign Neoplasms
- Neoplasms, Brain, Benign
- Brain Neoplasms, Benign
- Benign Brain Neoplasm
- Benign Brain Neoplasms
- Brain Neoplasm, Benign
Brain Tumor, Primary- Brain Tumor, Primary
- Brain Tumors, Primary
- Primary Brain Tumor
- Primary Brain Tumors
- Neoplasms, Brain, Primary
- Brain Neoplasm, Primary
- Brain Neoplasms, Primary
- Primary Brain Neoplasm
- Primary Brain Neoplasms
|
Below are MeSH descriptors whose meaning is more general than "Brain Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Brain Neoplasms".
This graph shows the total number of publications written about "Brain Neoplasms" by people in this website by year, and whether "Brain Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 11 | 2 | 13 |
1994 | 7 | 2 | 9 |
1995 | 13 | 0 | 13 |
1996 | 11 | 1 | 12 |
1997 | 12 | 4 | 16 |
1998 | 3 | 3 | 6 |
1999 | 9 | 4 | 13 |
2000 | 11 | 0 | 11 |
2001 | 10 | 1 | 11 |
2002 | 3 | 2 | 5 |
2003 | 13 | 1 | 14 |
2004 | 8 | 0 | 8 |
2005 | 14 | 1 | 15 |
2006 | 25 | 2 | 27 |
2007 | 15 | 2 | 17 |
2008 | 14 | 1 | 15 |
2009 | 22 | 2 | 24 |
2010 | 28 | 1 | 29 |
2011 | 29 | 3 | 32 |
2012 | 16 | 4 | 20 |
2013 | 29 | 2 | 31 |
2014 | 27 | 4 | 31 |
2015 | 22 | 1 | 23 |
2016 | 22 | 1 | 23 |
2017 | 16 | 1 | 17 |
2018 | 14 | 3 | 17 |
2019 | 16 | 1 | 17 |
2020 | 16 | 1 | 17 |
2021 | 15 | 1 | 16 |
2022 | 8 | 0 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Brain Neoplasms" by people in Profiles.
-
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial. Neuro Oncol. 2023 02 14; 25(2):339-350.
-
Glucose Infusion Induced Change in Intracellular pH and Its Relationship with Tumor Glycolysis in a C6 Rat Model of Glioblastoma. Mol Imaging Biol. 2023 Apr; 25(2):271-282.
-
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma. J Med Chem. 2022 12 08; 65(23):15642-15662.
-
Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1. Acta Neuropathol. 2023 01; 145(1):71-82.
-
Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma. Cancer Immunol Res. 2022 06 03; 10(6):770-784.
-
Novel therapeutics and drug-delivery approaches in the modulation of glioblastoma stem cell resistance. Ther Deliv. 2022 04; 13(4):249-273.
-
A retrospective analysis of the impact of the COVID-19 pandemic on staging at presentation of patients with invasive melanoma. J Am Acad Dermatol. 2022 10; 87(4):906-908.
-
Propranolol as therapy for cerebral cavernous malformations: a cautionary note. J Transl Med. 2022 04 05; 20(1):160.
-
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice. Clin Cancer Res. 2022 03 15; 28(6):1117-1126.
-
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13. Acta Neuropathol. 2022 03; 143(3):403-414.